CJC-1295: GHRH Analog Benefits, Dosage, and Stacking Guide

CJC-1295 Benefits

• Growth hormone amplification: CJC-1295 increases the amplitude of GH pulses from the pituitary. When stacked with ipamorelin (which increases frequency), the combination produces substantially higher GH output than either alone.
• Extended activity window: The modified half-life means a single injection produces GH stimulation for hours vs. minutes with natural GHRH, making it practical for clinical use.
• IGF-1 elevation: Clinical studies show significant IGF-1 increases with CJC-1295 use, correlating with body composition improvements.
• No cortisol spike: Unlike GHRPs (particularly GHRP-2 and hexarelin), CJC-1295 doesn't meaningfully raise cortisol or prolactin.

CJC-1295 Dosage and Timing

The DAC vs. no-DAC distinction matters significantly for dosing:

CJC-1295 without DAC (Mod GRF 1-29) — most common protocol:

• 100–200 mcg per injection, 1–3x daily
• Always combined with ipamorelin (200–300 mcg) in the same injection
• Inject subcutaneously, ideally away from food (fasting state for 30–60 min before/after)
• Timing: bedtime is most common; some protocols add a morning or pre-workout dose

CJC-1295 with DAC — less common:

• 2 mg once weekly or every 2 weeks (subcutaneous)
• Produces a sustained GH elevation rather than pulsatile pulses
• Some practitioners prefer no-DAC for more physiologic release

CJC-1295 vs Sermorelin

Many practitioners prefer CJC-1295 (no DAC) + ipamorelin over sermorelin alone because the dual-pathway approach produces stronger GH stimulation. Sermorelin has the advantage of FDA history and compounding pharmacy availability in states with stricter regulations.